MedPage Today on MSN
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents
Also from SGO: p53 reactivator active in advanced gynecologic cancers, "perfect" score in ...
On average, cold emails only have a 0.9% response rate. It’s hard to stand out in a crowded inbox, and it’s only going to get harder. New email sender guidelines have been out for a couple years now.
An objective response rate of 48.2% was observed with ifinatamab deruxtecan in these previously treated patients Discussions with global regulatory authorities underway SCLC is aggressive and ...
Cold emailing is a trusted marketing and selling tool. However, older techniques need to evolve over time to produce better results to align with recent trends. If you continue relying on outdated ...
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
Cohort 3 analysis from the BREAKWATER study shows objective response rate of 64% with BRAFTOVI plus cetuximab and FOLFIRI compared to 39% with standard-of-care treatment FOLFIRI with or without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results